CalciMedica (CALC) Times Interest Earned (2019 - 2026)
CalciMedica's (CALC) quarterly Times Interest Earned came in at -$17.59 in Q1 2026, down 21.02% YoY from -$22.27 in Q1 2025, and down 30.37% on a QoQ basis from -$13.49 in Q4 2025.
CalciMedica (CALC) Times Interest Earned (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Times Interest Earned data on file, last reported at -$17.59 in Q1 2026.
- Quarterly Times Interest Earned fell 21.02% year-over-year to -$17.59 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$15.71 (up 59.23% YoY) and the FY2025 annual result came in at -$0.25, up 8.8% from the prior year.
- Times Interest Earned declined to -$17.59 in Q1 2026, from -$13.49 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of -$1.81 in Q3 2025 to a low of -$117.88 in Q3 2023.
- A 5-year average of -$26.74 and a median of -$14.01 in 2025 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned sank 1004.21% — and 2024, when it surged 96.2%.
- Tracing CALC's Times Interest Earned over 5 years: stood at -$31.05 in 2022, then tumbled by 83.02% to -$56.83 in 2023, then jumped by 92.11% to -$4.48 in 2024, then sank by 201.08% to -$13.49 in 2025, then sank by 30.37% to -$17.59 in 2026.
- The last three Times Interest Earned figures came in at -$17.59 (Q1 2026), -$13.49 (Q4 2025), and -$1.81 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 2.82 |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.08 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.42 |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 76.86 |
| 10 | CalciMedica | 9.93 Mn | -8.69 Mn | - | -12.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.34 |
| Mar 31, 2026 | -17.59 |
| Dec 31, 2025 | -13.49 |
| Sep 30, 2025 | -1.81 |
| Jun 30, 2025 | -20.44 |
| Mar 31, 2025 | -14.53 |
| Sep 30, 2024 | -4.48 |
| Jun 30, 2024 | -10.14 |
| Mar 31, 2024 | -7.30 |
| Dec 31, 2023 | -56.83 |
| Sep 30, 2023 | -117.88 |
| Jun 30, 2023 | -10.55 |
| Mar 31, 2023 | -60.22 |
| Dec 31, 2022 | -31.05 |
| Sep 30, 2022 | -10.68 |
| Jun 30, 2022 | -8.78 |
| Mar 31, 2022 | -42.11 |
| Dec 31, 2021 | -207.17 |
| Sep 30, 2021 | -15.21 |
| Jun 30, 2021 | -19.21 |